Health Care & Life Sciences » Pharmaceuticals | Anhui Sunhere Pharmaceutical Excipients Co. Ltd.

Anhui Sunhere Pharmaceutical Excipients Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
-
44,273.00
48,785.60
52,883.60
77,198.40
Depreciation, Depletion & Amortization
-
-
10,969.30
11,806.80
13,527.80
16,114
Other Funds
6,973.80
7,033.20
149,837.40
1,000.00
18,074.70
670.20
Funds from Operations
25,889.30
36,943.90
55,531.30
61,055.90
66,603.00
94,209.70
Changes in Working Capital
-
-
10,045.50
479.00
3,076.30
12,936.30
Net Operating Cash Flow
25,889.30
36,943.90
45,485.80
60,576.90
69,679.40
81,273.40
Capital Expenditures
37,796.40
11,665.40
8,870.20
15,271.40
24,189.30
Sale of Fixed Assets & Businesses
15.30
184.20
39.80
116.80
48.80
Purchase/Sale of Investments
-
-
120,000.00
30,000.00
61,729.00
Net Investing Cash Flow
31,314.30
10,220.70
127,120.30
44,154.60
37,089.60
Cash Dividends Paid - Total
-
-
6,960.00
9,280.00
13,920.00
Issuance/Reduction of Debt, Net
2,300.00
2,300.00
-
-
-
Net Financing Cash Flow
4,673.80
9,333.20
142,877.40
8,280.00
31,994.70
Net Change in Cash
10,098.80
17,389.90
61,242.80
8,142.30
596.10
Free Cash Flow
11,907.10
25,278.50
36,615.60
45,305.50
45,490.10
Deferred Taxes & Investment Tax Credit
-
-
91.50
64.80
110.60
227.10
Net Assets from Acquisitions
-
-
-
-
74,678.10
Other Sources
6,466.80
1,260.40
1,710.00
1,000.00
-
Exchange Rate Effect
-
-
-
-
1.00

About Anhui Sunhere Pharmaceutical Excipients Co.

View Profile
Address
2 Hebin Road
Huainan Anhui 232007
China
Employees -
Website http://www.shanhe01.com
Updated 07/08/2019
Anhui Sunhere Pharmaceutical Excipients Co., Ltd. engages in the research, development, production, and sale of medical supplements. Its business areas include Pharmaceutical manufacturing and Site lease. Its products include cellulose and its derivative products, starch and its derivative products, and inorganic salts.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.